RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Temesgen Samuel to Cyclin-Dependent Kinase Inhibitor p21

Back to Details
This is a "connection" page, showing publications Temesgen Samuel has written about Cyclin-Dependent Kinase Inhibitor p21.
Temesgen Samuel
Connection Strength
0.154
Cyclin-Dependent Kinase Inhibitor p21
  1. Samuel T, Fadlalla K, Mosley L, Katkoori V, Turner T, Manne U. Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells. Anticancer Res. 2012 Jan; 32(1):61-71.
    View in: PubMed
    Score: 0.102
  2. Samuel T, Weber HO, Funk JO. Linking DNA damage to cell cycle checkpoints. Cell Cycle. 2002 May-Jun; 1(3):162-8.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support